Literature DB >> 10867250

Characterization of a diltiazem-lambda carrageenan complex.

M C Bonferoni1, S Rossi, F Ferrari, G P Bettinetti, C Caramella.   

Abstract

In the present paper the interaction between lambda carrageenan, a natural sulphated polysaccharide, and diltiazem HCl, a Ca channel blocking agent, was studied. Dialysis equilibria were performed to quantify the binding capacity of lambda carrageenan for diltiazem. The relevance of the interaction to hydrophilic matrix systems was confirmed: a relationship was found between the binding capacity and the release profiles of matrix tablets containing a fixed amount of drug and different percentages of lambda carrageenan. Dialysis equilibria in buffered media showed that the interaction is quite insensitive to the pH of the medium (in the range 1.8-6.8), while it is reduced by increasing ionic strength; this behaviour is in line with the importance of ionic bonds in diltiazem-carrageenan interaction. On the basis of the calculated binding capacity, the complex was prepared, dried and milled. A preliminary characterization of the diltiazem-carrageenan complex in the solid state was effected by means of X-ray and DSC analysis. The amount of drug going into solution from the complex was not significantly affected by the pH of the medium (in the range 1.8-6.8), while it was increased by increasing ionic strength.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867250     DOI: 10.1016/s0378-5173(00)00389-6

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices.

Authors:  Kiran S Bhise; Ravindra S Dhumal; Bhaskar Chauhan; Anant Paradkar; Shivajirao S Kadam
Journal:  AAPS PharmSciTech       Date:  2007-06-15       Impact factor: 3.246

Review 2.  Novel platforms for oral drug delivery.

Authors:  P Colombo; F Sonvico; G Colombo; R Bettini
Journal:  Pharm Res       Date:  2009-01-09       Impact factor: 4.200

3.  Prolonged intragastric drug delivery mediated by Eudragit® E-carrageenan polyelectrolyte matrix tablets.

Authors:  Ahmad Bani-Jaber; Leena Al-Aani; Hatim Alkhatib; Bashar Al-Khalidi
Journal:  AAPS PharmSciTech       Date:  2011-02-08       Impact factor: 3.246

4.  Influence of complex solubility on formulations based on lambda carrageenan and basic drugs.

Authors:  Carola Aguzzi; Maria Cristina Bonferoni; Maria Rosario Osorio Fortich; Silvia Rossi; Franca Ferrari; Carla Caramella
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

5.  Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.

Authors:  M C Bonferoni; S Rossi; F Ferrari; E Stavik; A Pena-Romero; C Caramella
Journal:  AAPS PharmSciTech       Date:  2000-06-17       Impact factor: 3.246

6.  Effect of drying methods on swelling, erosion and drug release from chitosan-naproxen sodium complexes.

Authors:  Kiran S Bhise; Ravindra S Dhumal; Anant R Paradkar; Shivajirao S Kadam
Journal:  AAPS PharmSciTech       Date:  2007-12-29       Impact factor: 3.246

7.  Drug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/λ-carrageenan complexes.

Authors:  Ruggero Bettini; Maria Cristina Bonferoni; Paolo Colombo; Laura Zanelotti; Carla Caramella
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

8.  Dual-Functioning Scaffolds for the Treatment of Spinal Cord Injury: Alginate Nanofibers Loaded with the Sigma 1 Receptor (S1R) Agonist RC-33 in Chitosan Films.

Authors:  Barbara Vigani; Silvia Rossi; Giuseppina Sandri; Maria Cristina Bonferoni; Marta Rui; Simona Collina; Francesca Fagiani; Cristina Lanni; Franca Ferrari
Journal:  Mar Drugs       Date:  2019-12-26       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.